Full Issue

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Sep/Oct 2021 - Volume 25, Number 5

Purchase or view individual articles by selecting the article in the table below...

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Individual Articles - Sep/Oct 2021 - Volume 25, Number 5
PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800> Allen Loyd V Jr	Sep/Oct 2021 Pg. 356
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products Uttaro Elizabeth, Zhao Fang, Schweighardt Anne	Sep/Oct 2021 Pg. 364-371
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Riepl Mike	Sep/Oct 2021 Pg. 372-377
Realities of Pharmaceutical Compounding in the Republic of Uzbekistan Umarov Ulugbek, Zdoryk Oleksandr, Kolisnyk Sergii, Fatkhullaeva Muyussar	Sep/Oct 2021 Pg. 378-384
It's Time for a New Philosophy Brunner Scott	Sep/Oct 2021 Pg. 386-387
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2 Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy	Sep/Oct 2021 Pg. 389-395
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved Allen Loyd V Jr	Sep/Oct 2021 Pg. 396-400
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes Allen Loyd V Jr	Sep/Oct 2021 Pg. 403-408
Calculations Stockton Shelly J	Sep/Oct 2021 Pg. 410
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412
Cilazapril 1-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 413
Clonidine 0.01-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 414
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 415
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 416
Haloperidol 0.5-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 417
Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 418
Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 419
Sorafenib 20-mg/mL in Oil Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 420
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli	Sep/Oct 2021 Pg. 422-426
Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base Lopalco Antonio, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio	Sep/Oct 2021 Pg. 427-430
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A	Sep/Oct 2021 Pg. 431-439
Return to Top